Galena Again Beats Investors' 'Shotgun' Opioid Claims Suit
The former Galena Biopharma Inc. has defeated for a second time a proposed class action over alleged misrepresentations regarding its fentanyl-based drug Abstral, with a New Jersey federal judge blasting investors'...To view the full article, register now.
Already a subscriber? Click here to view full article